Day: February 7, 2022

Internationally recognized experts bring extensive scientific and clinical research expertise in cancer immunology and immunotherapy LONDON, Feb. 07, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced the appointment of Alena Gros, Ph.D. and Ben Creelan, M.D. to its Scientific Advisory Board (SAB). “We are very pleased to welcome leading experts Dr. Gros and Dr. Creelan to our Scientific Advisory Board. With two ongoing clinical trials, CHIRON in non-small cell lung cancer (NSCLC) and THETIS in melanoma, their extensive research experience and deep clinical expertise with cell-based immunotherapies for the treatment of solid tumors will be invaluable as we continue to advance the clinical development...

BOCA RATON, Fla., Feb. 07, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman, President and CEO of First Wave BioPharma, will deliver a virtual presentation at the 2022 BIO CEO & Investor Conference. The event is taking place February 14-17, 2022, at the New York Marriott Marquis as a hybrid conference that allows virtual and in-person participation. Registered attendees at BIO CEO will be able to view an on-demand, pre-recorded presentation by Mr. Sapirstein highlighting First Wave’s business and recent corporate achievements, as well as anticipated milestones. Members of...

Minim, Inc.Liz Hitchcock Recognized by NH Business ReviewCompany Co-Founder Liz Hitchcock to be Honored Among State’s Top Female Business Leaders During Annual Ceremony on Thursday, February 24, 2022  MANCHESTER, NH, Feb. 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Minim, Inc. (NASDAQ: MINM), the creator of intelligent WiFi software and Motorola home networking products under an exclusive global brand license, today announces that Board Director Liz Hitchcock has been honored as one of NH Business Review’s Outstanding Women in Business in 2022. Hitchcock will be recognized during the virtual New Hampshire Outstanding Women in Business Reception on Thursday, February 24, from 11 a.m. – 12 p.m.   “I’m thrilled to see Liz Hitchcock celebrated for her success in driving innovation and developing workforce...

NEW ALBANY, Ohio, Feb. 07, 2022 (GLOBE NEWSWIRE) — CVG (NASDAQ: CVGI) announced today that Harold Bevis, President and Chief Executive Officer, and Christopher Bohnert, Chief Financial Officer, will participate in a virtual non-deal roadshow hosted by Colliers Securities on Tuesday, February 8, 2022. Management will meet virtually with investors to discuss the Company’s transformation strategy to drive sales diversification and improve profitability. For further information, please contact IR@CVGRP.com. About CVG CVG is a global provider of components, assemblies and systems to the traditional commercial vehicle market, the electric vehicle market, and the warehouse automation market. Information about the Company and its products is available on the internet at www.cvgrp.com. Investor Contact Christopher Bohnert, Chief Financial...

MIAMI, Feb. 07, 2022 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (MSO), today announced the opening of its 45th Florida dispensary, located in South Tampa. “I’m proud to see our Florida team continue to thoughtfully expand our presence throughout the state, leading with the quality of the locations we are securing and the new stores that we’re building,” said Jon Sandelman, Founder, Chairman and CEO of Ayr. “Combined with recent improvements in selection in our stores – Origyn Extracts, Secret Orchard Sun Gems and fruit-forward vapes, Big Pete’s Cookies, and enhanced flower offerings – we feel better than ever about customer experience throughout our 45-store Florida footprint. We still have more to do to realize our...

Delivers Strong Operating Results Driven by Strong Consumer Demand SPRINGDALE, Ark., Feb. 07, 2022 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (NYSE: TSN), one of the world’s largest food companies and a recognized leader in protein with leading brands including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp and State Fair, today reported the following results:(in millions, except per share data)     First Quarter        2022     2021Sales     $ 12,933   $ 10,460Operating Income       1,455     705           Net Income       1,126     472Less: Net Income Attributable to Noncontrolling Interests       5     5Net Income Attributable to Tyson     $ 1,121   $ 467           Net Income Per Share Attributable to Tyson     $ 3.07   $ 1.28           Adjusted1 Operating Income     $ 1,432   $ 1,025           Adjusted1...

CFO Mark Gallenberger to Retire, Serve in Transitional Role Experienced Senior Finance Executive, Mitch Cohen, to Join Cerence in Interim RoleBURLINGTON, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced that Mark Gallenberger, chief financial officer, will retire effective March 11, 2022. Gallenberger will remain with Cerence in an advisory role through mid-November 2022 to ensure continuity in the business and an orderly transition to a new CFO. Mitch Cohen, with significant years of serving as a chief financial officer and interim executive to a wide range of companies overseeing finance and reporting functions, has joined Cerence this week and will serve in an interim role to provide oversight of the finance organization. Cerence has retained Heidrick & Struggles,...

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following virtual investor conference in February: 11th Annual SVB Leerink Global Healthcare ConferenceFireside Chat: Thursday, February 17, 2022, 8:40 a.m. ET Webcast link of the 11th Annual SVB Leerink Global Healthcare Conference will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. An archived replay will be available for 90 days following the event. About Zai Lab Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is a patient-focused, innovative, commercial-stage, global biopharmaceutical company focused on...

HeadlinesDelivered second largest bookings quarter in the Company’s history Exceeded most profitability metrics for the quarter Secured initial revenue contribution from fitness products, a new mobility market Won another China-based two-wheeler customer Company lowers FY2022 guidanceBURLINGTON, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today reported its first quarter fiscal year 2022 results for the quarter ended December 31, 2021. Results Summary (1)(in millions, except per share data)      Three Months Ended          December 31,          2021       2020        GAAP Revenue     $94.4         $93.6        GAAP Gross Margin       74.3%           71.3%        Non-GAAP Gross Margin       77.5%           75.0%        GAAP Operating Margin       24.3%           18.7%        Non-GAAP...

– New Patent will Strengthen Company’s IP Portfolio – CARLSBAD, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that it has received “Notice of Allowance” for its patent from the United States Patent and Trademark Office (USPTO), for the invention: ‘Spinal Implant for Motion Preservation or Fusion’. This patent covers one of Aurora’s products in development, the ZIPFlexTM, which is a minimally invasive posterior non-fusion interspinous implant for motion preservation but can be converted to act as a fusion or non-fusion device while implanted in a patient via a small attachment. Mr. Trent Northcutt, President and Chief Executive...